ArticleMolecules (Basel, Switzerland)2026
Sara Jamal Meknas, Eveen Al-Shalabi, Rima Hajjo, Sanaa K Bardaweel, Ghassan Abushaikha, Kamal Sweidan, Swapnaa Balaji, Amit K Tiwari, Haizhen A Zhong, Dima A Sabbah
Abstract read
In one paragraphArticle in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Sara Jamal MeknasDepartment of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan.ORCID 0009-0001-1140-1307 Eveen Al-ShalabiDepartment of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan.
Rima HajjoDepartment of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan.ORCID 0000-0002-7090-5425 Sanaa K BardaweelDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Jordan, Amman 11942, Jordan.ORCID 0000-0002-4823-0708 Ghassan AbushaikhaDepartment of Medicinal and Biological Chemistry, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH 43606, USA.ORCID 0000-0001-6654-4658 Kamal SweidanDepartment of Chemistry, The University of Jordan, Amman 11942, Jordan.
Swapnaa BalajiDepartment of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH 43614, USA.
Amit K TiwariDepartment of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH 43614, USA.
Haizhen A ZhongDSC 309, Department of Chemistry, The University of Nebraska at Omaha, Omaha, NE 68182, USA.ORCID 0000-0002-5945-749X Dima A SabbahDepartment of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan.ORCID 0000-0003-1428-5097 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Cancer remains the second leading cause of death worldwide, highlighting the urgent need for novel therapeutic agents. In this work, twenty derivatives of
Indexed as
Antineoplastic AgentsQuinolonesCaco-2 CellsCell Line, TumorDrug Screening Assays, AntitumorHCT116 CellsHumansMolecular Docking SimulationMolecular StructureStructure-Activity RelationshipAntineoplastic AgentsQuinolonesanticancer agentscheminformaticsHCT-116N-benzyl-6-chloro-4-hydroxy-2-quinolone-3-carboxamidepathway analysisPC-3
Identifiers
PMID41752432
PMCPMC12943595
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390